nanoMaterials Discovery Corporation issues a voluntary nationwide recall of its Alcohol Antiseptic 80% Alcohol Solution.
The consumer-level recall affects all lots of the products branded “Snowy Range Blue” and packed in four fluid-ounce spray dispensers. The recall was initiated because certain batches of the product may exceed FDA’s recommended methanol limit.
Risk Statement
Alcohol Antiseptic 80% Alcohol Solution that exceeds FDA’s methanol limit could cause adverse reactions when used. The effects could be nausea, vomiting, blurred vision, headache, permanent blindness, seizures, coma, damage to the nervous system, and death.
Young children, adolescents, and adults who ingest this product either by accident or as alcohol are mostly at risk. To date, nanoMaterials Discovery Corporation has not received any reports of adverse reactions as a result of using this product.
Alcohol Antiseptic 80% Alcohol Solution is indicated for use as hand sanitizer for reducing bacterial contamination. It is used when water and soap are not within reach.
The product bears the code NDC 75288-100-04 and is packed in four fluid-ounce spray dispenser bottles. The affected lots of Alcohol Antiseptic, 80% Alcohol Solution, were distributed nationwide. The sales were discontinued in Q4 2021.
nanoMaterials Discovery Corporation is sending notifications about the recall to all its distributors by mail and is arranging for the return of the affected products.
Wholesalers, distributors, and retailers that still have an inventory of the product labelled “Snowy Range Blue” should stop any further distribution and either discard or return the products to nanoMaterials Discovery Corporations.
Consumers would also stop using these products and discard them immediately. Consumers with questions regarding this recall can email nanoMaterials Discovery Corporation at [email protected].
Consumers who have experienced any adverse reactions related to the use of this product should contact their healthcare providers immediately.
Adverse reactions or quality issues related to this recall would be reported to FDA’s MedWatch Adverse Event Reporting program by filling out the online form, requesting reporting form through 1- 800-332-1088 and sending it through regular mail, or faxing to 1-800-FDA-0178.
